Positron Emission Tomography (PET) Market to Reach USD 1.36 Billion by 2030, Driven by Oncology and Neurology Applications

Mordor Intelligence has published a new report on positron emission tomography (PET) market offering a comprehensive analysis of trends, growth drivers, and future projection

Introduction

The positron emission tomography market is poised for steady growth, with the market size expected to reach USD 1.36 billion by 2030, up from USD 1.13 billion in 2025. This growth reflects a compound annual growth rate (CAGR) of 3.71%, highlighting the expanding adoption of PET imaging in healthcare, particularly in oncology, neurology, and cardiology. The increasing burden of cancer and neurodegenerative diseases worldwide is driving demand for high-sensitivity molecular imaging, while hospitals and diagnostic centers invest in advanced PET scanners for early diagnosis and therapy monitoring.

Report Overview:

https://www.mordorintelligence.com/industry-reports/positron-emission-tomography-pet-market?utm_source=openpr

Key Trends

The positron emission tomography PET market trends are shaped by several factors that support growth across diverse healthcare settings:

Expansion of Total-Body PET Scanners: Total-body PET platforms offer ten-fold sensitivity improvements, allowing whole-body scans in under a minute and significantly reducing tracer doses. These advancements are encouraging hospitals to replace legacy scanners with newer, more efficient systems.

Artificial Intelligence Integration: AI-powered PET/CT analysis tools now enable rapid identification of multiple cancer types, improving diagnostic accuracy and reducing radiologist workload. Software-bundled scanners are increasingly assessed for their lifetime value alongside detector performance.

Rising Clinical Demand in Oncology and Neurology: Oncology continues to contribute the largest share of PET scans, while neurology shows the fastest growth rate. PET imaging is critical for early-stage cancer detection, monitoring treatment response, and assessing neurological disorders such as Parkinson's disease.

Radiopharmaceutical Development: Growing demand for PET tracers, including 18F-FDG and 68Ga-PSMA, is driving investment in radiopharmaceutical production. Centralized cyclotron networks in emerging markets support consistent tracer supply for PET imaging centers.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:

https://www.mordorintelligence.com/ja/industry-reports/positron-emission-tomography-pet-market?utm_source=openpr

Market Segmentation

The positron emission tomography PET market analysis is structured across multiple segments:

By Product Type (Value)

Full-Ring PET Scanners

Partial-Ring PET Scanners

By Modality

Stand-Alone PET

PET/CT

PET/MRI

By Radiotracer / Isotope

18F-Fluorodeoxyglucose (18F-FDG)

68Ga-Based Tracers (DOTATATE, PSMA)

82Rb & 13N-Ammonia (Cardiac)

64Cu & Zirconium-89 Immuno-PET

By Application

Oncology

Cardiology

Neurology

Inflammation & Other

By End-User

Hospitals

Diagnostic Imaging Centers

Others

By Geography

North America

Europe

Asia-Pacific

Middle East & Africa

South America

Hospitals remain the dominant end-user segment due to the critical role of PET imaging in patient management, while diagnostic centers are expanding rapidly as outpatient imaging demand rises. North America leads in market share, whereas Asia-Pacific shows the highest growth potential, fueled by investments in imaging infrastructure and cyclotron facilities.

Key Players

The positron emission tomography PET market size is supported by competitive activity among major global players. Companies focus on scanner performance, service contracts, and software integration to enhance market share. Leading players emphasize:

Agfa Healthcare

Oncovision

CMR Naviscan

General Electric Company (GE Healthcare)

Neusoft Corporation

These strategies help providers maintain high utilization rates, particularly in oncology and neurology, while ensuring reliable access to tracers for diagnostic and therapeutic applications.

Conclusion

The positron emission tomography PET market growth is underpinned by increasing demand for precision imaging in oncology, neurology, and cardiology. Advances in total-body PET scanners, AI-enabled diagnostics, and expanded radiopharmaceutical networks are enhancing the efficiency and effectiveness of PET imaging. With hospitals and diagnostic centers investing in modern imaging equipment, the market is set to expand steadily, particularly in regions such as Asia-Pacific. The combination of clinical demand, technological adoption, and supportive infrastructure ensures that the positron emission tomography PET market will continue to grow and play a key role in modern healthcare diagnostics.

For complete market analysis, please visit the Mordor Intelligence page:

https://www.mordorintelligence.com/industry-reports/positron-emission-tomography-pet-market?utm_source=openpr

Industry related Reports:

Europe Nuclear Medicine Market : The Europe Nuclear Medicine Market is categorized based on diagnostics, therapeutics, applications, and geography. In diagnostics, it includes Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET), while therapeutics cover Alpha Emitters, Beta Emitters, and Brachytherapy. Applications span Cardiology, Neurology, Oncology, and other areas. Geographically, the market is analyzed across Germany, the UK, France, Italy, Spain, and the Rest of Europe. The report provides the market value in USD million for each of these segments.

Get more Insights: https://www.mordorintelligence.com/industry-reports/europe-nuclear-medicine-market?utm_source=openpr

APAC Ovarian Cancer Diagnostics & Therapeutics Market : The Asia-Pacific Ovarian Cancer Diagnostics and Therapeutics Market is segmented based on cancer type, diagnosis methods, treatment options, and geography. Cancer types include epithelial ovarian tumors, ovarian germ cell tumors, and others, while diagnostic approaches cover blood tests, PET, CT scans, and more. Treatment options span chemotherapy, immunotherapy, radiation therapy, among others. Geographically, the market analysis focuses on key countries such as China, Japan, India, and additional nations across the region.

Get mor Insights: https://www.mordorintelligence.com/industry-reports/asia-pacific-ovarian-cancer-diagnostics-and-therapeutics-market?utm_source=openpr

United States Nuclear Imaging Market : The United States nuclear imaging market is projected to grow from USD 3.20 billion in 2025 to USD 3.88 billion by 2030, at a 3.94% CAGR, driven by precision PET, solid-state detector upgrades, and expanding theranostic pipelines. Medicare's separate reimbursement for high-value radiopharmaceuticals and FDA approvals of novel PET agents accelerate adoption over SPECT. Supply-chain challenges and vertical integration by equipment suppliers further shape the competitive landscape and domestic isotope production.

Get more Insights: https://www.mordorintelligence.com/industry-reports/united-states-nuclear-imaging-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.